ADDF-Full-Logo-WhiteADDF-Logo-Text-WhiteADDF-Full-Logo-WhiteADDF-Full-Logo-White
  • Agenda
  • About
  • Sponsors
  • Live Labs
    • Oral Drug Delivery
    • Artificial Intelligence
    • Past Programs
  • Contact
Registration Open
✕
  • Filter by
  • Categories
  • Show all
  • All
  • Agenda
  • Homepage
  • Advancing Drug Development Forum
    0
    Date
    November 18, 2025
    10 dec 2026: returns to umass club Conversations connecting science, strategy & business
  • Sponsorship — Partnership & Progress
    0
    Date
    November 18, 2025
    Partner in shaping the future of pharma Support programs where strategy meets science and help drive the breakthroughs transforming drug development.
  • Hands-On Science & Problem Solving
    0
    Date
    November 18, 2025
    Where bold science meets real-world challenges The Live Lab series offers scientists the opportunity to discover practical solutions through active experimentation and peer discussion.
  • Exceptional Speakers & Strategic Insight
    0
    Date
    November 18, 2025
    Leading voices. Unfiltered conversations. Each year, ADDF attendees hear from industry-leaders like Dr. Jeremy M. Levin, author of Biotech in the Balance, as they share lessons […]
Copyright © 2026 Advancing Drug Development Forum - All Rights Reserved.
Registration Open

Keynote: Biotech Leadership The Long View

A rare, candid conversation with Harvey Berger on building—and rebuilding—companies at the cutting edge of science. From pioneering cancer therapies to shaping the next generation of biotech leadership, his journey will inspire, challenge, and equip you to think bigger about what’s possible in drug development.

Expect hard-won lessons on leading through uncertainty, aligning teams through pivots, and developing leaders who can scale ideas from concept to clinic.

Harvey Berger , Chairman and Chief Executive Officer of Arena BioWorks, LLC
Moderator: Alok Tayi , CEO, Vibe Bio, Biotech 2050
Harvey Berger Shokworks Logo

Fireside Chat: Transformation of the Boston Biotech

The Fireside Chat ignites the stage with Boston’s biotech trailblazers in a raw, no-filter conversation about what’s driving transformation right now. Expect bold perspectives, unvarnished lessons, and breakthrough ideas that challenge the status quo and spark new possibilities. This is where the energy peaks, the insights get real, and the future of drug development takes shape in front of you.

Joshua Cohen , Founder & CEO, Amylyx Pharmaceuticals
Brad Loncar, Founder, BiotechTV
Ivana Magovcevic-Liebisch, PhD, JD , Chief Executive Officer and President, Vigil Neuroscience
Court Square Group Logo

Scaling Up Without Falling Apart: Can Culture Keep Up With Growth?

Moving from Biotech Startup to Operational Excellence

Scaling up isn’t just about headcount and funding—it’s about bringing in the right people at the right time. This session dives into how leaders can protect and evolve corporate culture while building organizations that move fast without losing focus. Hear candid insights from executives who have lived the tension between growth and culture, and learn what it really takes to scale with strength and stability.

Nele Van Dessel , CEO, Ernest Pharmaceuticals
Baruch Harris , COO, Pretzel Therapeutics
Justin Klee , Founder & CEO, Amylyx Pharmaceuticals
Catherine Smith , Executive Director, The Termeer Foundation
Moderator: Margaret “Missy” Fulton , Founder & CEO, Chameleon Strategies, LLC
Scaling Culture Panel
SOPPhC Logo Spectrum Pharma Packaging Logo

Far East InLicensing: The New Research Powerhouse

Biopharmaceutical deals with Asian partners have long centered on services, with Asian firms as providers and US/EU sponsors as innovators. That pattern is shifting: more Asian companies now lead with novel pipelines and pursue innovation-led licensing and M&A.

Expect guidance on scouting and diligence; deal structures; IP and data protection; and co-development models that transfer know-how.

Patrick Bench , Founder and President, Benchmark Strategies
Roger Frechette , Member Board of Directors, Jeevan Therapeutics
Simon McGurk , VP Strategic External Development, GSK
Brian Yang , Managing Editor Citeline and Sr Writer, Informa
Moderator: David Sharrow , Partner, Orrick
Far East InLicensing Panel

Investments Amid Market & Political Uncertainty

How policy, market perception, and macroeconomic pressure are reshaping the biotech investment landscape.

Fundraising looks different this cycle. Fundraising looks different this cycle. Many are insulated from broader market swings, so headlines can mislead. From a macro vantage, this panel shows where capital is actually flowing—and what it means for timing, milestones, and deal structure amid market and political noise.

Chris Garabedian , Portfolio Manager, Perceptive Advisors
Meg Krench , Investor, Sanofi Ventures
Danielle O’Neal , Senior VP, Banc of California
David Setboun , Chief Operating Officer, Alkeus
Kirk Taylor , President/CEO, Mass Life Science
Moderator: Warren Browne , Founder & CEO, Browne Consulting
Investments Panel SCx CMC Solutions Logo

Afternoon Keynote: RNA-Targeted Small Molecules (RSMs) Are Pushing the Boundaries of Drug Development

Get ready for a bold and brilliant keynote from Jennifer Petter, the trailblazing founder of Arrakis Therapeutics. As a pioneer in RNA-targeted small molecules, Jennifer is rewriting the rules of drug discovery—pushing scientific boundaries, defying conventional thinking, and revealing how breakthrough ideas can become game-changing therapies. This is the future of drug development, delivered firsthand.

Jennifer Petter , Founder & Chief Scientific + Innovation Officer, Arrakis Therapeutics

From China to Canada: Rethinking Pharma Supply Chain Strategies

“As Heraclitus once opined, ‘Change is the only constant.’”

Few areas in drug development are more impacted—and more impactful—than the supply chain, where logistics remain in flux amid tariff pressure and reshoring.

This discussion examines regional risk, dual sourcing, tech-enabled visibility, and how to future-proof material and manufacturing plans when “normal” keeps shifting.

Kurt Nielsen , Managing Partner, Expert Insights
Elizabeth Rebeil , Veranova, Global VP Supply Chain and Operational Excellence
Gil Roth , President, Pharma and Biopharma Outsourcing Association
Moderator: Ben Locwin , Reliant Life Sciences
Supply Chain Panel Orrick Logo

Overcoming the Pitfalls of Getting Prepared for a Clinical Trial

Step inside the real-world challenges of getting clinical trials off the ground and why so many are happening outside the U.S. Our expert panel pulls no punches as they unpack the hidden pitfalls, regulatory hurdles, and operational missteps that can derail even the most promising programs, while sharing the strategies that can turn setbacks into successful, on-time launches.

Gina Matarazzo , Managing Director, Sallop Insurance Agency, Inc.
Craig Mooney , Global Head of IRT, Taikun Pharma Services
Lois Rosenberger , Founder, LBR Regulatory and Clinical Consulting Services
Sara Tylosky , CEO, Farmacon
Clinical Trial Panel Taikun Pharma Services Logo

AI in Pharma: Can It Really Accelerate Development Timelines?

Our cross-functional panel looks past the buzz to where AI is already earning time back through predictive modeling, smarter trial design, and faster decision cycles. Hear from leaders across the industry and discover how AI is already transforming the way we discover, develop, and deliver new therapies.

Learn what’s working, what isn’t, and how to scope AI use cases that move real endpoints.

Kevin J Bittorf , Founder & Principal Consultant, SCx CMC Solutions
Quinn Johns , CEO, EITRI AI
Keith Parent , CEO & Owner, Court Square Group
Alok Tayi , CEO, Vibe Bio, Biotech 2050
AI in Pharma Panel Temperature Excursions Logo